Drug intelligence / Profile preview

VAIO Powder

Development stage: Unknown
Lead developer: Ronyd Healthcare
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Oral

Overview

VAIO Powder is a nutritional supplement developed and marketed by Ronyd Healthcare, an Indian pharmaceutical and nutraceutical company. The product is formulated as a protein powder enriched with Docosahexaenoic acid (DHA), Gamma-linolenic acid (GLA), and a variety of essential vitamins and minerals. It is designed to provide comprehensive nutritional support, aiding in the maintenance of overall health, supporting growth and development, and addressing dietary deficiencies. As a branded generic nutraceutical, it is available over-the-counter and is commonly used as a dietary adjunct to bridge nutritional gaps and support metabolic functions.

Brand names: VAIO Powder

Targets

MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on VAIO Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAIO Powder.

Explore the full profile